Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CING stock hub

Cingulate Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

CINGis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
64.6M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
CING
In the news

Latest news · CING

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-450.6
P25 -105.6P50 -46.5P75 -3.1
ROIC-104.5
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All CING market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
183
Groups with data
11
Currency
USD
Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

24
MetricValue
Cik
0001862150
Company name
Cingulate Inc.
Country
United States
Country code
US
Cusip
17248W105
Employees
14
Employees Change
1%
Employees Change Percent
7.69
Enterprise value
$62.4M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Biotechnology
IPO Date
2021-12-08
Isin
US17248W3034
Last refreshed
2026-05-10
Market cap
$64.6M
Market cap category
Micro-Cap
Price
$5.27
Price currency
USD
Sector
Healthcare
Sic
2834
Symbol
CING
Website
https://www.cingulate.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

3
MetricValue
Earnings Yield
-34.77%
FCF yield
-26.96%
P/B ratio
15.23x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

9
MetricValue
Gross Profit
$-9.8M
Net Income
$-22.4M
Net Income Growth Years
0%
Profit Per Employee
$-1.6M
ROA
-83.25
Roa5y
-95.87
ROCE
-418.8
ROE
-450.6
ROIC
-104.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

4
MetricValue
Cagr1y
33.78%
Cagr3y
-72.7%
EPS Growth Years
4
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

18
MetricValue
Assets
$15.1M
Cash
$11M
Current Assets
$12M
Current Liabilities
$10.3M
Debt
$8.8M
Debt Equity
$3.5
Equity
$2.5M
Interest Coverage
-11.52
Liabilities
$12.6M
Long Term Assets
$3.1M
Long Term Liabilities
$2.3M
Net Cash
$2.2M
Net Cash By Market Cap
$3.36
Net Cash Growth
-69.53%
Net Debt Equity
$-0.86
Tangible Book Value
$2.5M
Tangible Book Value Per Share
$0.35
WACC
1.67

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
1.16
Net Working Capital
$-2.7M
Quick ratio
1.06
Working Capital
$1.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-231.54%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
1Y total return
33.76%
200-day SMA
4.93
3Y total return
-97.97%
50-day SMA
6.37
50-day SMA vs 200-day SMA
50over200
All Time High
1,236
All Time High Change
-99.57%
All Time High Date
2021-12-08
All Time Low
1.8
All Time Low Change
192.78%
All Time Low Date
2024-08-14
ATR
0.53
Beta
-0.81
Beta1y
-0.2
Beta2y
5.24
Ch YTD
21.43
High
5.3
High52
11.89
High52 Date
2026-03-17
High52ch
-55.68%
Low
5.02
Low52
3.2
Low52 Date
2025-11-17
Low52ch
64.69%
Ma50ch
-17.23%
Premarket Change Percent
3.06
Premarket Price
$5.39
Premarket Volume
1,606
Price vs 200-day SMA
6.9%
RSI
45.28
RSI Monthly
36.59
RSI Weekly
48.43
Sharpe ratio
0.73x
Sortino ratio
1.15
Total Return
-231.54%
Tr YTD
21.43
Tr1m
-11.28%
Tr1w
-1.86%
Tr3m
-31.56%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

10
MetricValue
Analyst Count
2
Analyst Count Top
1
Analyst Price Target Top
$14
Analyst Ratings
Strong Buy
Analyst Ratings Top
Strong Buy
Earnings EPS Estimate
$-0.53
Operating Income
$-19.9M
Price target
$34.5
Price Target Change
$555
Price Target Change Top
$166

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

11
MetricValue
Float
11,914,048%
Float Percent
97.25%
Net Borrowing
5,995,570
Shares Insiders
1.08%
Shares Institutions
23.58%
Shares Out
12,250,564
Shares Qo Q
23.99%
Shares Yo Y
231.54%
Short Float
11.93%
Short Ratio
2.11
Short Shares
11.6

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

59
MetricValue
Adjusted FCF
$-18.9M
Average Volume
472,648.45x
Bv Per Share
0.35
CAPEX
$-162,138
Ch1m
-11.28
Ch1w
-1.86
Ch1y
33.76
Ch3m
-31.56
Ch3y
-97.97
Ch6m
41.29
Change
0.76%
Change From Open
0.19
Close
5.23
Days Gap
0.57
Depreciation Amortization
540,894
Dollar Volume
1,378,869.2
Earnings Date
2026-05-22
Earnings Time
bmo
EBIT
$-19.9M
EBITDA
$-19.4M
EPS
$-4.44
F Score
2
FCF
$-17.4M
FCF EV Yield
-27.9x
FCF Per Share
$-1.42
Financing CF
16,149,382
Fiscal Year End
December
Founded
2,012
Investing CF
-162,138
Ipr
-12.17
Iprfo
-99.56
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-03-18
Last Report Date
2025-12-31
Last Split Date
2024-08-09
Last Split Type
Reverse
Last10k Filing Date
2026-03-18
Ma150
5.18
Ma150ch
1.78%
Ma20
5.33
Ma20ch
-1.11%
Net CF
-1,257,938
Next Earnings Date
2026-05-22
Open
5.26
Optionable
Yes
Position In Range
89.29
Post Close
5.27
Postmarket Change Percent
1.14
Postmarket Price
$5.33
Ppne
3,065,005
Pre Close
5.23
Price Date
2026-05-08
Ptbv Ratio
25.73
Relative Volume
0.55x
Share Based Comp
1,523,828
Tr6m
41.29%
Us State
Kansas
Volume
261,645
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does CING pay a dividend?

Capital-return profile for this ticker.

Performance

CING stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+33.8%
S&P 500 1Y: n/a
3Y total return
-98.0%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns CING?

Insider, institutional, and short-interest positioning.

Institutional ownership
+23.6%
Float: +97.3% of shares outstanding
Insider ownership
+1.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+11.9%
2.1 days to cover
Y/Y dilution
+231.5%
Negative means the company is buying back shares.
Technical

CING momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
45.3
Neutral momentum band
Price vs 200-day MA
+6.9%
50/200-day relationship not available
Beta (5Y)
-0.81
Less volatile than the market
Sharpe ratio
0.73
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About CING

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CING stock rating?

Cingulate Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CING analysis?

The full report lives at /stocks/CING/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CING?

The latest report frames CING around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CING page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.